TG Therapeutics, Inc. (TGTX)
55.98
-0.72
(-1.28%)
USD |
NASDAQ |
Sep 04, 16:00
55.50
-0.48
(-0.87%)
Pre-Market: 09:16
TG Therapeutics Research and Development Expense (% of Annual Revenues)
Research and Development Expense (% of Annual Revenues) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (% of Annual Revenues) Data
| Date | Value |
|---|---|
| December 31, 2025 | -- |
| December 31, 2024 | -- |
| December 31, 2023 | -- |
| December 31, 2022 | -- |
| December 31, 2021 | -- |
| December 31, 2020 | -- |
| December 31, 2019 | -- |
| December 31, 2018 | -- |
| December 31, 2017 | -- |
| Date | Value |
|---|---|
| December 31, 2016 | -- |
| December 31, 2015 | -- |
| December 31, 2014 | -- |
| December 31, 2013 | -- |
| December 31, 2012 | -- |
| December 31, 2002 | -- |
| December 31, 2001 | -- |
| December 31, 2000 | -- |
| December 31, 1999 | -- |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (% of Annual Revenues) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median